Health Condition 1: J869- Pyothorax without fistula
Conditions
Interventions
Intervention1: 0.5 % of 0.3 ml/kg of ropivacaine with 50 ug/kg of morphine (group M): patients will receive ultrasound guided single site paravertebral block at 5th space with 0.3ml/kg of ropivicaine
Sponsors
Amber Rawat
Eligibility
Inclusion criteria
Inclusion criteria: 1.) Children in ASA1 and 2 physical health undergoing lung decortication surgery for pyothorax 2.) Parents consenting for participation in the study
Exclusion criteria
Exclusion criteria: 1.) ASA physical status more than 2 . 2.) Parents not consenting for participation in the study. 3.) Allergy to ropivacaine, morphine or dexmedetomidine 4.) Coagulopathy 5.) Local site infection 6.) Renal, hepatic , cardiac or mental dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.) Haemodynamic stability measured by HR(heart rate) and BP(Blood pressure) 2.) Intensity of pain measured by VAS( Visual Analogue Scale) 2.) Duration of analgesiaTimepoint: HR(heart rate) and BP(Blood pressure) To be measured every 5 minutes during the surgery. 2.) Intensity of pain measured by VAS( Visual Analogue Scale) every 4 hours after surgery completion till first 24 hours after surgery 2.) Duration of analgesia will be evaluated every 4 hours till administration of rescue analgesia | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.)Total dose of rescue analgesic (tramadol) consumption in the first 24 hours. 2.) Bradycardia or hypotension 3.) Nausea and vomitingTimepoint: Every 4 hourly from the end of surgery till 1st 24 hours after surgery | — |
Countries
India
Contacts
Public ContactAmber Rawat
institute of medical sciences
Outcome results
None listed